BioStem Technologies, Inc.

US$1.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BSEMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (17.43%)
Div yield —
ROE (74.74%)
Biotechnology
Beta (5Y) 0.69
PE TTM —
TSR TTM (76.68%)
Mkt cap US$21.00M
ROIC (107.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.35
19.70%
(94.74%)
Hold 6|2|12|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.03
0.03
0.03
24.03%
23.71%
22.84%
20.20%
Revenue$M
2.111
2.125
2.122
2.116
8.27%
6.89%
5.87%
1.37%
Peers (US$21.00M)
Cap (US$)
PE
21.48M
—
20.68M
—
20.83M
99.41x
Capital
TTM
5Y
10Y
Leveragex
0.472
0.030
0.033
EBIT/Intx
1.390
0.240
0.244
Own earn%
284.58
(16.22)
(21.61)
Sh yield%
35.54
46.68
46.79
Owners
Insiders/Inst%
3.17
63.26
Short interest%
3.12
SBC / revenue%
0.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
7–12
$1 testx
0.4
Incr. ROIC%
2